A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

547

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2015

Conditions
Myeloid Leukemia, Chronic
Interventions
DRUG

Dasatinib

Tablets, oral, dasatinib 50-140 mg once daily (QD)

DRUG

Imatinib

Tablets, oral, imatinib 200-800 mg, QD

Trial Locations (109)

11

Local Institution, Lima

34

Local Institution, Lima

1021

Local Institution, Buenos Aires

1090

Local Institution, Vienna

1097

Local Institution, Budapest

1200

Local Institution, Brussels

1280

Local Institution, Capital Federal

2298

Local Institution, Waratah

4012

Local Institution, Debrecen

4029

Local Institution, Brisbane

4120

Local Institution, Greenslopes

6020

Local Institution, Innsbruck

8000

Local Institution, Bruges

Local Institution, Aarhus

10043

Local Institution, Orbassano (to)

13083

Local Institution, Campinas

13353

Local Institution, Berlin

14000

Local Institution, Mexico City

15706

Local Institution, A Coruña

17210

Local Institution, Jaú

18055

Local Institution, Rostock

20900

Local Institution, Monza (mb)

27100

Local Institution, Pavia

28006

Local Institution, Madrid

28046

Local Institution, Madrid

29010

Local Institution, Málaga

29609

Local Institution, Brest

31059

Local Institution, Toulouse

31501

Local Institution, Krakow

33006

Local Institution, Oviedo

34295

Local Institution, Montpellier

35033

Local Institution, Rennes

37007

Local Institution, Salamanca

38039

Local Institution, Kayseri

40138

Local Institution, Bologna

44093

Local Institution, Nantes

46009

Local Institution, Valencia

54511

Local Institution, Vandœuvre-lès-Nancy

57010

Local Institution, Thessaloniki

59037

Local Institution, Lille

60869

Local Institution, Poznan

64460

Local Institution, Monterrey

67091

Local Institution, Strasbourg

69495

Local Institution, Pierre-Bénite

72076

Local Institution, Tübingen

75015

Local Institution, Paris

75475

Local Institution, Paris

80060

Local Institution, Curitiba

80230

Local Institution, Culiacán

86021

Local Institution, Poitiers

87042

Local Institution, Limoges

89081

Local Institution, Ulm

95124

Local Institution, Catania

97219

Molecular Md, Portland

100044

Local Institution, Beijing

125167

Local Institution, Moscow

169865

Local Institution, Singapore

197022

Local Institution, Saint Petersburg

200025

Local Institution, Shanghai

300020

Local Institution, Tianjin

344022

Local Institution, Rostov-on-Don

350001

Local Institution, Fuzhou

380009

Local Institution, Ahmedabad

400010

Local Institution, Mumbai

400012

Local Institution, Mumbai

400014

Local Institution, Mumbai

632004

Local Institution, Vellore

682304

Local Institution, Kochi

695011

Local Institution, Trivandrum

1418625

Local Institution, Shinagawa-ku

2968602

Local Institution, Kamogawa-shi

6028566

Local Institution, Kyoto

7008558

Local Institution, Okayama

20230130

Local Institution, Rio de Janeiro

C1114AAN

Local Institution, Capital Federal

WA 6000

Local Institution, Perth

01401

Local Institution, São Paulo

05403

Local Institution, São Paulo

Unknown

Local Institution, Santiago

Local Institution, Colombia

Local Institution, Bogotá

Local Institution, Sendai

Local Institution, Arequipa

625 00

Local Institution, Brno

500 05

Local Institution, Hradec Králové

775 20

Local Institution, Olomouc

128 20

Local Institution, Prague

00144

Local Institution, Roma

00161

Local Institution, Roma

466-8650

Local Institution, Nagoya

814-0180

Local Institution, Fukuoka

020-8505

Local Institution, Morioka

890-0064

Local Institution, Kagoshima

232-0024

Local Institution, Yokohama

545-8586

Local Institution, Osaka

113-8677

Local Institution, Bunkyo-ku

02990

Local Institution, Mexico City

06726

Local Institution, Mexico, D. F.

9700 RB

Local Institution, Groningen

6500 HB

Local Institution, Nijmegen

41-500

Local Institution, Chorzów

93-510

Local Institution, Lodz

02776

Local Institution, Warsaw

137-040

Local Institution, Seoul

138-736

Local Institution, Seoul

08003

Local Institution, Barcelona

08036

Local Institution, Barcelona

08907

Local Institution, Barcelona

06100

Local Institution, Ankara

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY